LONDON, March 12, 2019 /PRNewswire/ — Smith & Nephew plc (LSE: SN,NYSE: SNN), the global medical technology business, announces that it has agreed to acquire Osiris Therapeutics, Inc. (NASDAQ: OSIR), a fast growing company delivering regenerative medicine products, including skin, bone graft and articular cartilage substitutes, for $19.00 per share in cash, representing a total equity value of approximately $660 million. Namal Nawana, …